Kiribati

The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the rotavirus vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 515 ICERs from 68 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.

The dataset contains predictions of the incremental cost-effectiveness ratios (ICERs) for the HPV vaccine in 195 countries. Predictions are based on meta-regression estimates of ICERs on three sets of independent variables (true variation measured by country characteristics, intervention characteristics, and bias variables). Data used in the meta-regression analysis are 613 ICERs from 75 studies in the Tufts University’s cost-effectiveness analysis registries, and additional extractions of ICERs for sensitivity analyses.

This dataset contains annual spending estimates on immunizations for 135 low- and middle-income countries (as determined by the World Bank) from 2000 through 2017. The estimates are disaggregated by spending source — government, out-of-pocket, prepaid private, and development assistance for immunization — and immunization component or activity: e.g., vaccine costs, delivery costs, and routine and supplementary immunizations. Data used to produce the estimates came from National Health Accounts, Joint Reporting Forms, comprehensive multi-year plans, databases from Gavi, the Vaccine Alliance, and the Institute for Health Metrics and Evaluation’s 2019 Development Assistance for Health Database. Estimates are reported in 2019 United States Dollars (USD).